ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CVRS Corindus Vascular Robotics Inc

4.27
0.00 (0.00%)
16 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Corindus Vascular Robotics Inc AMEX:CVRS AMEX Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.27 0 00:00:00

Corindus to Report Second Quarter 2019 Financial Results on August 8, 2019

25/07/2019 11:45am

Business Wire


Corindus Vascular Robotics (AMEX:CVRS)
Historical Stock Chart


From Jan 2020 to Jan 2025

Click Here for more Corindus Vascular Robotics Charts.

Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced that it will release second quarter 2019 financial and business results on Thursday, August 8, 2019 before the open of the U.S. financial markets.

Mark Toland, President and Chief Executive Officer, and David Long, Chief Financial Officer, will host a conference call to discuss the results as follows:

   

Date

 

Thursday, August 8, 2019

   

Time

 

8:30 a.m. EDT

   

Toll free (U.S.)

 

(833) 286-5802

   

International

 

(647) 689-4447

   

Conference ID:

 

7795032

   

Webcast (live and replay)

 

www.corindus.com under the ‘Investor Relations’ section.

About Corindus Vascular Robotics, Inc.

Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The Company’s CorPath® platform is the first FDA-cleared medical device to bring robotic precision to percutaneous coronary and vascular procedures. CorPath GRX is the second-generation robotic-assisted technology offering enhancements to the platform by adding important key upgrades that increase precision, improve workflow, and extend the capabilities and range of procedures that can be performed robotically. We are focused on developing innovative robotic solutions to revolutionize treatment of emergent conditions by providing specialized and timely medical care to patients around the world. For additional information, visit www.corindus.com, and follow @CorindusInc.

Media Contact: Matter for Corindus Jessica Wolter T: 978-518-4536 corindus@matternow.com www.matternow.com

Investor Contact: Lisa Wilson In-Site Communications, Inc. T: 917-543-9932 ir@corindus.com

1 Year Corindus Vascular Robotics Chart

1 Year Corindus Vascular Robotics Chart

1 Month Corindus Vascular Robotics Chart

1 Month Corindus Vascular Robotics Chart